XML 44 R32.htm IDEA: XBRL DOCUMENT v3.25.2
SHARE-BASED COMPENSATION (Tables)
 9 Months Ended
Aug. 03, 2025
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on the Company’s share-based compensation expenses.
   
Three Months Ended
    
Nine Months Ended
  
   
August 3,
    
July 28,
    
August 3,
    
July 28,
  
   
2025
    
2024
    
2025
    
2024
  
Expense reported in:
                        
Cost of goods sold
  
$
816
    
$
683
    
$
2,378
    
$
1,946
  
Selling, general, and administrative
    
2,174
      
2,388
      
6,729
      
7,126
  
Research and development
    
304
      
271
      
896
      
769
  
Total expense incurred
  
$
3,294
    
$
3,342
    
$
10,003
    
$
9,841
  
                                 
Expense by award type:
                                
Restricted stock awards
  
$
2,943
    
$
3,342
    
$
9,029
    
$
9,841
  
Restricted stock units
    
294
      
-
      
803
      
-
  
Employee stock purchase plan
    
57
      
-
      
171
      
-
  
Total expense incurred
  
$
3,294
    
$
3,342
    
$
10,003
    
$
9,841
  
                                 
Income tax benefits on share-based compensation
  
$
461
    
$
323
    
$
1,313
    
$
745
  
Restricted Stock Awards Activity The table below presents information on the Company’s restricted stock awards
   
Three Months Ended
    
Nine Months Ended
  
   
August 3,
    
July 28,
    
August 3,
    
July 28,
  
   
2025
    
2024
    
2025
    
2024
  
Number of shares granted in period
    
-
      
-
      
583,238
      
825,050
  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
-
    
$
-
    
$
23.42
    
$
29.77
  
Compensation cost not yet recognized
  
$
24,414
    
$
25,750
    
$
24,414
    
$
25,750
  
Weighted-average amortization period for cost not yet recognized (in years)
    
2.8
      
2.9
      
2.8
      
2.9
  
Shares outstanding at balance sheet date
    
1,421,897
      
1,513,827
      
1,421,897
      
1,513,827
  
Restricted Stock Units Activity The table below presents information on the Company’s restricted stock unit awards.
   
Three Months Ended
    
Nine Months Ended
  
   
August 3,
    
July 28,
    
August 3,
    
July 28,
  
   
2025
    
2024
    
2025
    
2024
  
Number of units granted in period
    
109,830
      
-
      
162,666
      
-
  
Weighted-average grant-date fair value of awards (in dollars per share)
  
$
18.21
    
$
-
    
$
19.61
    
$
-
  
Compensation cost not yet recognized
  
$
2,387
    
$
-
    
$
2,387
    
$
-
  
Weighted-average amortization period for cost not yet recognized (in years)
    
3.3
      
-
      
3.3
      
-
  
Restricted stock units outstanding at balance sheet date
    
132,474
      
-
      
132,474
      
-
  
Stock Options Activity The table below presents information on the Company’s stock options.
   
Three Months Ended
    
Nine Months Ended
  
   
August 3,
    
July 28,
    
August 3,
    
July 28,
  
   
2025
    
2024
    
2025
    
2024
  
Number of options granted in period
    
-
      
-
      
-
      
-
  
Cash received from options exercised
  
$
400
    
$
20
    
$
1,698
    
$
1,074
  
Compensation cost not yet recognized
  
$
-
    
$
-
    
$
-
    
$
-
  
Weighted-average amortization period for cost not yet recognized (in years)
    
-
      
-
      
-
      
-
  
Outstanding and Exercisable Option
Information regarding outstanding and exercisable option awards as of August 3, 2025, is presented below.

   









   




Weighted



   


Weighted
Average



   


Average
Remaining

Aggregate
   


Exercise
Contractual

Intrinsic  
Options
  
Shares
     Price
Life (in years)

Value  
Outstanding and exercisable at August 3, 2025

115,075

$
 10.31

1.88

$
 1,091